Percentage distribution of maternal deaths by cause of death, PDHS 2007 and PMMS 2019. by Farid Midhet (17403945)

Subjects:

Maternal mortality ratio (MMR) by cause of death, per 100,000 live births, PDHS 2007 and PMMS 2019. by Farid Midhet (17403945)

Subjects:

Mean lesion depth of the SDF test groups and the SDF-free group at baseline and post-cycling time points. by Suphanida Kaewkamchai (19762172)

Subjects:

Comparison of the association between maternal mortality and antenatal care and skilled birth attendance in the last pregnancy; Pakistan 2007 and 2019 (see notes 2, 3). by Farid Midhet (17403945)

Subjects:

MMR (maternal deaths per 100,000 live births) and 95% confidence limits by urban and rural areas, PDHS 2007 and PMMS 2019. by Farid Midhet (17403945)

Subjects:

Comparison of biological and socioeconomic risk factors of maternal mortality, in Pakistan (PDHS 2007 and PMMS 2019) (see note 1). by Farid Midhet (17403945)

Subjects:

Model testing results across different boxers with 15% of training dataset. by Saravanan Manoharan (21273304)

Subjects:

MMR (maternal deaths per 100,000 live births) and 95% confidence limits, PDHS 2007 and PMMS 2019. by Farid Midhet (17403945)

Subjects:

Mean mineral density of the SDF test groups and the SDF-free group at baseline and post-cycling time points. by Suphanida Kaewkamchai (19762172)

Subjects:

Expert annotation of uncertain instances to refine model training. by Saravanan Manoharan (21273304)

Subjects:

Representative SEM images of the dentin surface topography of the three SDF test groups and the SDF-free group. by Suphanida Kaewkamchai (19762172)

Subjects:

Typical X-ray diffraction patterns of the dentin of the three SDF treated groups and the control group. by Suphanida Kaewkamchai (19762172)

Subjects:

Accuracy metrics with different percentage of the training dataset. by Saravanan Manoharan (21273304)

Subjects:

The viability of <i>S</i>. <i>mutans</i> and <i>C</i>. <i>albicans</i> (log CFU/ml) and the wet weight of dual-species biofilms (mg) of the experimental and the control groups afte... by Suphanida Kaewkamchai (19762172)

Subjects:

Participant flow (CONSORT diagram). by David J. Diemert (8135568)

“…Peak anti-<i>Na</i>-GST-1 IgG levels were observed between 2 and 4 weeks following the third dose, regardless of <i>Na</i>-GST-1 formulation. IgG levels decreased but remained significantly above baseline in all groups by day 290, at which point all participants (20 of 20 evaluable participants) still had detectable IgG. …”

Fig 1 - Fusing multisensory signals across channels and time by Swathi Anil (17382903)

Representative restriction enzyme-digested products on a 2% agarose gel. by Md. Akeruzzaman Shaon (21511929)

Comparison of cats in the petting groups who contacted the researcher’s hand vs. those who did not. by Allison Andrukonis (11846404)

Growth characteristics of <i>A. baumannii</i> strains used in this study. by Techit Thavorasak (13138440)

(a) The diameter distribution of magnetic nanoparticles and (b) the magnetization curve of the ferrofluid. by Amirhossein Favakeh (21417884)